CCDC69 and breast cancer: Meanwhile, compared with small size in BC (T1–3) and pathologic stages (Stage II-IV) in BC patients, the expression of CCDC69 was obviously below in large size (T4) and advanced pathological stage (Stage IV) patients (P < 0.001, P = 0.019) (Figures 2C,D).